Page 1 of Clinical Trials for Boehringer Ingelheim Pharmaceuticals [SPONSOR-COLLABORATORS], 707 Total Matches
- 1CompletedLast Updated: May 18, 2012Condition(s): Parkinson Disease
- 2CompletedLast Updated: October 6, 2009Condition(s): Pulmonary Disease, Chronic Obstructive; Asthma
- 3CompletedLast Updated: May 18, 2012Condition(s): Atrial Fibrillation; Stroke
- 4CompletedLast Updated: May 18, 2012Condition(s): Cystic Fibrosis
- 5CompletedLast Updated: May 2, 2012Condition(s): Diabetes Mellitus, Type 2
- 6RecruitingLast Updated: May 2, 2012Condition(s): HIV Infections
- 7TerminatedLast Updated: September 19, 2005Condition(s): Cystic Fibrosis
- 8CompletedLast Updated: May 18, 2012Condition(s): HIV Infections; Quality of Life
- 9CompletedLast Updated: May 18, 2012Condition(s): Parkinson Disease
- 10CompletedLast Updated: May 18, 2012Condition(s): Parkinson Disease
- 11RecruitingLast Updated: May 2, 2012Condition(s): Arthroplasty, Replacement; Thromboembolism
- 12Active, not recruitingLast Updated: May 2, 2012Condition(s): Diabetes Mellitus, Type 2; Renal Insufficiency
- 13CompletedLast Updated: June 1, 2011Condition(s): Healthy
- 14CompletedLast Updated: May 2, 2012Condition(s): Diabetes Mellitus, Type 2
- 15Completed
- 16CompletedLast Updated: April 11, 2011Condition(s): Cardiovascular Diseases
- 17TerminatedLast Updated: May 18, 2012Condition(s): Asthma
- 18RecruitingLast Updated: May 2, 2012Condition(s): Stroke; Atrial Fibrillation
- 19CompletedLast Updated: May 11, 2012Condition(s): Cerebrovascular Accident
- 20TerminatedLast Updated: May 18, 2012Condition(s): HIV Infections
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Boehringer+Ingelheim+Pharmaceuticals
